Virophta en es it fr

Virophta Brand names, Virophta Analogs

Virophta Brand Names Mixture

  • No information avaliable

Virophta Chemical_Formula

C41H42N4O8

Virophta RX_link

http://www.rxlist.com/cgi/generic2/verteporfin.htm

Virophta fda sheet

Virophta FDA

Virophta msds (material safety sheet)

Virophta Synthesis Reference

No information avaliable

Virophta Molecular Weight

718.794 g/mol

Virophta Melting Point

No information avaliable

Virophta H2O Solubility

No information avaliable

Virophta State

Solid

Virophta LogP

3.743

Virophta Dosage Forms

Powder for solution to be mixed for injection (2mg verteporfin/mL reconstituted verteporfin)

Virophta Indication

For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.

Virophta Pharmacology

Verteporfin, otherwise known as benzoporphyrin derivative, is a medication used in conjunction with laser treatment to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels.

Virophta Absorption

No information avaliable

Virophta side effects and Toxicity

Overdose of drug and/or light in the treated eye may result in nonperfusion of normal retinal vessels with the possibility of severe decrease in vision that could be permanent. An overdose of drug will also result in the prolongation of the period during which the patient remains photosensitive to bright light.

Virophta Patient Information

Virophta Organisms Affected

Humans and other mammals